| 8:30-9:00 | Introduction/Convocation |
| Session I: | Overview of Vitamin D (25 minute talks with 5 minute Q & A) |
| 9:00-9:30 | Historical Overview of Vitamin D from a Public Health Perspective
Speaker: Mike Holick, Boston University |
| 9:30-10:00 | Vitamin D Biology: Overview General Physiology, and Function of Vitamin D
Speaker: Hector Deluca, University of Wisconsin-Madison |
| 10:00-10:30 | Vitamin D: A Global Perspective
Speaker: Gerald Combs, USDA/ARS/HNRCGF |
| 10:30-11:00 | BREAK |
| Session 2: | Epidemiology, Demographics and Methodologies (20 Minute Talks-10 Minute Q & A)
Session Chair: Anne Looker, NCHS/CDC |
| 11:00-11:30 | Current Data on Prevalence in the United States: Age and Racial Risk Groups
Speaker: Kelley Scanlon, CDC |
| 11:30-12:00 | Vitamin D Assessment: A Global Perspective of Needs and Current Concerns
Speaker: Christel Lamberg-Allardt, University of Helsinki, Finland |
| 12:00-12:30 | Biomarkers: Functional Indices of Vitamin D Status and Functional Ramifications of Marginal or Deficient Status
Speaker: Robert Heaney, Creighton University |
| 12:30-1:00 | Vitamin D Fortification: Data Needs and Current Status
Speaker: Mona Calvo, FDA |
| 1:00-2:00 | LUNCH |
| 2:00-2:30 | Panel Discussion 1: Questions |
1. What are five research priorities?
2. What are the major needs with regard to methodologies? |
| Session 3: | Current Understanding of the Role of Vitamin D in Health and Potential Mechanisms for Vitamin D-Related Disease (20 Minute Talks-10 Minute Q & A)
Session Chair: Gerald Combs, USDA/ARS/HNRCGF |
| 2:30-3:00 | Overview of Potential Association between Vitamin D, UV Exposure, and Disease
Speaker: William B. Grant, Newport News, VA |
| 3:00-3:30 | Vitamin D and the Immune System
Speaker: Margherita Cantorna, Penn State University |
| 3:30-4:00 | Vitamin D and Cancer: Case Study of Vitamin D and Breast Cancer
Speaker: JoEllen Welsh, Notre Dame University |
| 4:00-4:30 | Nutritional Rickets: Vitamin D, Calcium, or Both?
Speaker: John Pettifor, University of Witwatersand, South Africa |
| 4:30-4:45 | BREAK |
| 4:45-5:15 | New Methodologies for Probing the Role(s) of Vitamin D in Health
Speaker: Jim Fleet, Purdue University |
| 5:15-5:45 | Panel Discussion 2: Questions |
1. What are the five priority areas in the vitamin D/disease relationship?
2. What are the current obstacles (e.g., methodologies) for the exploration of the vitamin D/health relationship?
3. What is the best approach to addressing vitamin D and health in the international setting? |
| 6:00-9:00 | Conference Reception: Bethesda Marriott Hotel, 5151 Pooks Hill Road |
| Friday, October 10, 2003 |
| Session 4: | Developmental, Ethnic/Racial Considerations in Generating Recommendations for Vitamin D (20-Minute Talks-10 Minute Q & A)
Session Chair: TBA |
| 9:00-9:30 | Overview of Current Vitamin D Recommendations
Speaker: Connie Weaver, Purdue University |
| 9:30-10:00 | Pregnancy
Speaker: Bonnie Specker, South Dakota State University |
| 10:00-10:30 | Prenatal/Fetal and Infant Predictors of Bone Health
Speaker: Nicolas Bishop, University of Sheffield |
| 10:30-11:00 | BREAK |
| 11:00-11:30 | Lactation
Speaker: Bruce Hollis, Medical University of South Carolina |
| 11:30-12:00 | Issues in Establishing Recommendations for Infants and Children
Speaker: Frank Greer, Meriter Hospital, Madison, WI |
| 12:00-12:30 | Adults/Elderly
Speaker: Bess Dawson-Hughes, Tufts University |
| 12:30-1:30 | LUNCH |
| 1:30-2:30 | Panel Discussion 3: Questions |
1. Are the current dietary recommendations for vitamin D adequate?
2. What are the research priorities: data needs to set meaningful recommendations for different developmental and/or racial/ethnic groups?
3. Given the current state of knowledge what are the public health approaches to achieve vitamin D adequacy?
4. What factors need to be considered with regard to amount, duration, and target groups for dietary or other (UV exposure) interventions/recommendations?
5. How can we account for potential confluence of health messages to create adverse outcomes (UV protection vs. vitamin D adequacy)?
6. Is there a need for special considerations for health disparities? |
| Session 5: | Conclusions/Recommendations: Summary Discussion
Panel: session chairs, organizers, representatives from sponsoring agencies |
| 2:30- 3:00 | Questions: |
1. What are key research/program priorities?
2. What are the key program priorities for your agency/program?
3. How best to coordinate agency/organization response to current data needs/public health issues? |
| ADJOURN |
